Patient_ID
stringlengths 8
8
| Age
int64 18
89
| Gender
stringclasses 2
values | Weight_kg
float64 50.2
100
| Height_cm
float64 150
200
| Comorbidities
stringclasses 4
values | Previous_Treatments
stringclasses 3
values | Tumor_Histology
stringclasses 4
values | Tumor_Grade
stringclasses 3
values | Tumor_Stage
stringclasses 4
values | Imaging_Modality
stringclasses 3
values | Image_Resolution
stringclasses 2
values | Scan_Type
stringclasses 2
values | Scanner_Manufacturer
stringclasses 3
values | Gross_Tumor_Volume_cm3
float64 1.22
150
| Clinical_Target_Volume_cm3
float64 0.96
200
| Planning_Target_Volume_cm3
float64 1.47
249
| Beam_Arrangements
stringclasses 2
values | Dose_Distributions_Gy
float64 10.2
99.8
| Optimization_Objectives
stringclasses 3
values | Dose_Volume_Histogram
stringlengths 9
9
| Synthetic_Image_Path
stringlengths 41
41
| GTV_Segmentation_Path
stringlengths 45
45
| CTV_Segmentation_Path
stringlengths 45
45
| PTV_Segmentation_Path
stringlengths 45
45
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SIM-0301 | 38 | Female | 66.3 | 152.2 | Hypertension | Surgery | Meningioma | High | IV | CT | Anisotropic | Non-Contrast-Enhanced | Philips | 116.71 | 114.58 | 79.44 | Single | 93.7 | Balanced | DVH_P0301 | /simulated/path/P0301_synthetic_image.nii | /simulated/path/SIM-0301_GTV_segmentation.nii | /simulated/path/SIM-0301_CTV_segmentation.nii | /simulated/path/SIM-0301_PTV_segmentation.nii |
SIM-0302 | 31 | Female | 59.8 | 156.6 | Hypertension | null | Meningioma | High | III | PET | Isotropic | Contrast-Enhanced | Siemens | 74.66 | 79.23 | 155.2 | Single | 27.72 | Organ-Sparing | DVH_P0302 | /simulated/path/P0302_synthetic_image.nii | /simulated/path/SIM-0302_GTV_segmentation.nii | /simulated/path/SIM-0302_CTV_segmentation.nii | /simulated/path/SIM-0302_PTV_segmentation.nii |
SIM-0303 | 69 | Male | 52.5 | 182.5 | Cancer History | Chemotherapy | Glioblastoma | High | III | CT | Isotropic | Contrast-Enhanced | Philips | 104.04 | 24.26 | 68.12 | Multi-Beam | 25.6 | Organ-Sparing | DVH_P0303 | /simulated/path/P0303_synthetic_image.nii | /simulated/path/SIM-0303_GTV_segmentation.nii | /simulated/path/SIM-0303_CTV_segmentation.nii | /simulated/path/SIM-0303_PTV_segmentation.nii |
SIM-0304 | 40 | Female | 69.5 | 186.5 | Hypertension | Chemotherapy | Metastatic | Intermediate | II | CT | Isotropic | Contrast-Enhanced | Philips | 98.9 | 177.98 | 197.96 | Multi-Beam | 92.89 | Maximize Tumor Dose | DVH_P0304 | /simulated/path/P0304_synthetic_image.nii | /simulated/path/SIM-0304_GTV_segmentation.nii | /simulated/path/SIM-0304_CTV_segmentation.nii | /simulated/path/SIM-0304_PTV_segmentation.nii |
SIM-0305 | 34 | Female | 99.2 | 153.3 | Cardiac Issues | Radiotherapy | Astrocytoma | Intermediate | III | CT | Anisotropic | Contrast-Enhanced | Siemens | 107.91 | 78.14 | 29.04 | Multi-Beam | 49.04 | Organ-Sparing | DVH_P0305 | /simulated/path/P0305_synthetic_image.nii | /simulated/path/SIM-0305_GTV_segmentation.nii | /simulated/path/SIM-0305_CTV_segmentation.nii | /simulated/path/SIM-0305_PTV_segmentation.nii |
SIM-0306 | 67 | Male | 77.2 | 165.1 | Cancer History | Surgery | Glioblastoma | Low | II | CT | Anisotropic | Contrast-Enhanced | Siemens | 149.03 | 115.9 | 95.92 | Multi-Beam | 86.23 | Maximize Tumor Dose | DVH_P0306 | /simulated/path/P0306_synthetic_image.nii | /simulated/path/SIM-0306_GTV_segmentation.nii | /simulated/path/SIM-0306_CTV_segmentation.nii | /simulated/path/SIM-0306_PTV_segmentation.nii |
SIM-0307 | 65 | Male | 60.7 | 184.8 | Hypertension | Chemotherapy | Metastatic | Intermediate | I | CT | Isotropic | Contrast-Enhanced | GE | 6.65 | 4.59 | 28.93 | Multi-Beam | 58.6 | Balanced | DVH_P0307 | /simulated/path/P0307_synthetic_image.nii | /simulated/path/SIM-0307_GTV_segmentation.nii | /simulated/path/SIM-0307_CTV_segmentation.nii | /simulated/path/SIM-0307_PTV_segmentation.nii |
SIM-0308 | 34 | Female | 73.8 | 169.6 | Hypertension | null | Meningioma | High | IV | PET | Anisotropic | Contrast-Enhanced | Philips | 20.98 | 30.12 | 145.07 | Single | 58.29 | Organ-Sparing | DVH_P0308 | /simulated/path/P0308_synthetic_image.nii | /simulated/path/SIM-0308_GTV_segmentation.nii | /simulated/path/SIM-0308_CTV_segmentation.nii | /simulated/path/SIM-0308_PTV_segmentation.nii |
SIM-0309 | 19 | Female | 95.1 | 179.3 | Hypertension | null | Meningioma | High | III | PET | Isotropic | Contrast-Enhanced | GE | 130.03 | 51.83 | 56.17 | Multi-Beam | 88.95 | Balanced | DVH_P0309 | /simulated/path/P0309_synthetic_image.nii | /simulated/path/SIM-0309_GTV_segmentation.nii | /simulated/path/SIM-0309_CTV_segmentation.nii | /simulated/path/SIM-0309_PTV_segmentation.nii |
SIM-0310 | 78 | Male | 67.1 | 190.3 | Diabetes | Radiotherapy | Astrocytoma | Low | I | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 67.33 | 81.12 | 92.14 | Multi-Beam | 65.61 | Maximize Tumor Dose | DVH_P0310 | /simulated/path/P0310_synthetic_image.nii | /simulated/path/SIM-0310_GTV_segmentation.nii | /simulated/path/SIM-0310_CTV_segmentation.nii | /simulated/path/SIM-0310_PTV_segmentation.nii |
SIM-0311 | 51 | Male | 89 | 152.6 | Diabetes | Chemotherapy | Metastatic | Low | III | MRI | Anisotropic | Contrast-Enhanced | Siemens | 9.65 | 150.13 | 52.24 | Single | 75.05 | Balanced | DVH_P0311 | /simulated/path/P0311_synthetic_image.nii | /simulated/path/SIM-0311_GTV_segmentation.nii | /simulated/path/SIM-0311_CTV_segmentation.nii | /simulated/path/SIM-0311_PTV_segmentation.nii |
SIM-0312 | 52 | Male | 97.8 | 164.9 | Diabetes | Surgery | Metastatic | Low | IV | PET | Anisotropic | Non-Contrast-Enhanced | Philips | 94.66 | 162.37 | 173.4 | Single | 93.92 | Maximize Tumor Dose | DVH_P0312 | /simulated/path/P0312_synthetic_image.nii | /simulated/path/SIM-0312_GTV_segmentation.nii | /simulated/path/SIM-0312_CTV_segmentation.nii | /simulated/path/SIM-0312_PTV_segmentation.nii |
SIM-0313 | 30 | Male | 56.3 | 159.9 | Cardiac Issues | Radiotherapy | Glioblastoma | Low | I | MRI | Isotropic | Non-Contrast-Enhanced | Philips | 57.22 | 11.92 | 94.87 | Single | 80.12 | Balanced | DVH_P0313 | /simulated/path/P0313_synthetic_image.nii | /simulated/path/SIM-0313_GTV_segmentation.nii | /simulated/path/SIM-0313_CTV_segmentation.nii | /simulated/path/SIM-0313_PTV_segmentation.nii |
SIM-0314 | 36 | Female | 51.1 | 160.2 | Hypertension | null | Glioblastoma | Intermediate | IV | PET | Anisotropic | Non-Contrast-Enhanced | Philips | 107.53 | 197.05 | 129.32 | Multi-Beam | 76.77 | Balanced | DVH_P0314 | /simulated/path/P0314_synthetic_image.nii | /simulated/path/SIM-0314_GTV_segmentation.nii | /simulated/path/SIM-0314_CTV_segmentation.nii | /simulated/path/SIM-0314_PTV_segmentation.nii |
SIM-0315 | 21 | Female | 93.4 | 173.2 | Cancer History | null | Meningioma | Low | III | MRI | Anisotropic | Contrast-Enhanced | GE | 73.36 | 96.26 | 24.42 | Multi-Beam | 26.94 | Maximize Tumor Dose | DVH_P0315 | /simulated/path/P0315_synthetic_image.nii | /simulated/path/SIM-0315_GTV_segmentation.nii | /simulated/path/SIM-0315_CTV_segmentation.nii | /simulated/path/SIM-0315_PTV_segmentation.nii |
SIM-0316 | 37 | Female | 75.3 | 183.8 | Cardiac Issues | Surgery | Metastatic | Intermediate | III | PET | Isotropic | Non-Contrast-Enhanced | Philips | 43.67 | 98.38 | 211.03 | Single | 78.09 | Balanced | DVH_P0316 | /simulated/path/P0316_synthetic_image.nii | /simulated/path/SIM-0316_GTV_segmentation.nii | /simulated/path/SIM-0316_CTV_segmentation.nii | /simulated/path/SIM-0316_PTV_segmentation.nii |
SIM-0317 | 42 | Male | 67.1 | 158.9 | Diabetes | Radiotherapy | Astrocytoma | High | II | PET | Isotropic | Non-Contrast-Enhanced | Philips | 111.72 | 113.09 | 78.11 | Single | 57.56 | Balanced | DVH_P0317 | /simulated/path/P0317_synthetic_image.nii | /simulated/path/SIM-0317_GTV_segmentation.nii | /simulated/path/SIM-0317_CTV_segmentation.nii | /simulated/path/SIM-0317_PTV_segmentation.nii |
SIM-0318 | 26 | Female | 80.1 | 177.9 | Hypertension | null | Metastatic | High | I | CT | Isotropic | Contrast-Enhanced | Philips | 32.45 | 59.29 | 34.8 | Multi-Beam | 33.64 | Balanced | DVH_P0318 | /simulated/path/P0318_synthetic_image.nii | /simulated/path/SIM-0318_GTV_segmentation.nii | /simulated/path/SIM-0318_CTV_segmentation.nii | /simulated/path/SIM-0318_PTV_segmentation.nii |
SIM-0319 | 66 | Male | 88.7 | 188.4 | Cardiac Issues | Chemotherapy | Metastatic | Intermediate | II | PET | Anisotropic | Contrast-Enhanced | Philips | 18.18 | 143.28 | 222.17 | Single | 25.91 | Organ-Sparing | DVH_P0319 | /simulated/path/P0319_synthetic_image.nii | /simulated/path/SIM-0319_GTV_segmentation.nii | /simulated/path/SIM-0319_CTV_segmentation.nii | /simulated/path/SIM-0319_PTV_segmentation.nii |
SIM-0320 | 42 | Female | 91.5 | 189 | Cardiac Issues | Chemotherapy | Metastatic | Low | I | CT | Isotropic | Contrast-Enhanced | GE | 59.53 | 21.5 | 61.37 | Single | 12.02 | Organ-Sparing | DVH_P0320 | /simulated/path/P0320_synthetic_image.nii | /simulated/path/SIM-0320_GTV_segmentation.nii | /simulated/path/SIM-0320_CTV_segmentation.nii | /simulated/path/SIM-0320_PTV_segmentation.nii |
SIM-0321 | 32 | Male | 96.7 | 155.1 | Cardiac Issues | Radiotherapy | Glioblastoma | Low | III | CT | Isotropic | Non-Contrast-Enhanced | GE | 63.01 | 96.73 | 134.92 | Multi-Beam | 87.28 | Maximize Tumor Dose | DVH_P0321 | /simulated/path/P0321_synthetic_image.nii | /simulated/path/SIM-0321_GTV_segmentation.nii | /simulated/path/SIM-0321_CTV_segmentation.nii | /simulated/path/SIM-0321_PTV_segmentation.nii |
SIM-0322 | 66 | Female | 86.7 | 163 | Diabetes | Chemotherapy | Meningioma | Low | II | CT | Anisotropic | Non-Contrast-Enhanced | GE | 119.31 | 74.23 | 143.26 | Multi-Beam | 50.14 | Organ-Sparing | DVH_P0322 | /simulated/path/P0322_synthetic_image.nii | /simulated/path/SIM-0322_GTV_segmentation.nii | /simulated/path/SIM-0322_CTV_segmentation.nii | /simulated/path/SIM-0322_PTV_segmentation.nii |
SIM-0323 | 62 | Female | 81.6 | 186.5 | null | Radiotherapy | Astrocytoma | High | II | PET | Anisotropic | Non-Contrast-Enhanced | GE | 42.96 | 78.98 | 160.15 | Single | 33.85 | Balanced | DVH_P0323 | /simulated/path/P0323_synthetic_image.nii | /simulated/path/SIM-0323_GTV_segmentation.nii | /simulated/path/SIM-0323_CTV_segmentation.nii | /simulated/path/SIM-0323_PTV_segmentation.nii |
SIM-0324 | 21 | Male | 85.2 | 190.5 | null | Chemotherapy | Metastatic | High | III | MRI | Isotropic | Non-Contrast-Enhanced | GE | 70.59 | 80.63 | 158.1 | Multi-Beam | 67.67 | Balanced | DVH_P0324 | /simulated/path/P0324_synthetic_image.nii | /simulated/path/SIM-0324_GTV_segmentation.nii | /simulated/path/SIM-0324_CTV_segmentation.nii | /simulated/path/SIM-0324_PTV_segmentation.nii |
SIM-0325 | 46 | Female | 66.1 | 158.3 | Hypertension | Chemotherapy | Meningioma | High | III | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 8.78 | 149.68 | 12.65 | Single | 63.43 | Organ-Sparing | DVH_P0325 | /simulated/path/P0325_synthetic_image.nii | /simulated/path/SIM-0325_GTV_segmentation.nii | /simulated/path/SIM-0325_CTV_segmentation.nii | /simulated/path/SIM-0325_PTV_segmentation.nii |
SIM-0326 | 21 | Female | 79.7 | 150.6 | Diabetes | Surgery | Glioblastoma | Low | I | CT | Anisotropic | Contrast-Enhanced | GE | 56.22 | 3.48 | 113.3 | Single | 49.03 | Balanced | DVH_P0326 | /simulated/path/P0326_synthetic_image.nii | /simulated/path/SIM-0326_GTV_segmentation.nii | /simulated/path/SIM-0326_CTV_segmentation.nii | /simulated/path/SIM-0326_PTV_segmentation.nii |
SIM-0327 | 77 | Female | 93.4 | 181.8 | null | null | Astrocytoma | High | I | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 38.85 | 150.11 | 146.36 | Single | 72.71 | Organ-Sparing | DVH_P0327 | /simulated/path/P0327_synthetic_image.nii | /simulated/path/SIM-0327_GTV_segmentation.nii | /simulated/path/SIM-0327_CTV_segmentation.nii | /simulated/path/SIM-0327_PTV_segmentation.nii |
SIM-0328 | 86 | Male | 61.5 | 182.3 | Cardiac Issues | null | Metastatic | Intermediate | I | PET | Anisotropic | Non-Contrast-Enhanced | Philips | 40.54 | 129.52 | 186.11 | Multi-Beam | 16.97 | Balanced | DVH_P0328 | /simulated/path/P0328_synthetic_image.nii | /simulated/path/SIM-0328_GTV_segmentation.nii | /simulated/path/SIM-0328_CTV_segmentation.nii | /simulated/path/SIM-0328_PTV_segmentation.nii |
SIM-0329 | 85 | Male | 70.6 | 195.5 | Hypertension | null | Metastatic | Low | I | PET | Isotropic | Contrast-Enhanced | GE | 129.19 | 152.9 | 177.76 | Single | 67.96 | Maximize Tumor Dose | DVH_P0329 | /simulated/path/P0329_synthetic_image.nii | /simulated/path/SIM-0329_GTV_segmentation.nii | /simulated/path/SIM-0329_CTV_segmentation.nii | /simulated/path/SIM-0329_PTV_segmentation.nii |
SIM-0330 | 69 | Female | 96 | 197.9 | Cancer History | Chemotherapy | Meningioma | High | II | MRI | Isotropic | Non-Contrast-Enhanced | Philips | 124.2 | 161.24 | 22.46 | Multi-Beam | 90.59 | Organ-Sparing | DVH_P0330 | /simulated/path/P0330_synthetic_image.nii | /simulated/path/SIM-0330_GTV_segmentation.nii | /simulated/path/SIM-0330_CTV_segmentation.nii | /simulated/path/SIM-0330_PTV_segmentation.nii |
SIM-0331 | 72 | Male | 88.7 | 198.3 | Hypertension | null | Metastatic | High | I | CT | Isotropic | Contrast-Enhanced | Philips | 120.26 | 142.75 | 27.72 | Single | 55.24 | Balanced | DVH_P0331 | /simulated/path/P0331_synthetic_image.nii | /simulated/path/SIM-0331_GTV_segmentation.nii | /simulated/path/SIM-0331_CTV_segmentation.nii | /simulated/path/SIM-0331_PTV_segmentation.nii |
SIM-0332 | 40 | Male | 64.9 | 196.2 | Cardiac Issues | Chemotherapy | Meningioma | Low | III | CT | Isotropic | Non-Contrast-Enhanced | Philips | 66.74 | 129.63 | 222.25 | Single | 42.35 | Organ-Sparing | DVH_P0332 | /simulated/path/P0332_synthetic_image.nii | /simulated/path/SIM-0332_GTV_segmentation.nii | /simulated/path/SIM-0332_CTV_segmentation.nii | /simulated/path/SIM-0332_PTV_segmentation.nii |
SIM-0333 | 27 | Male | 50.9 | 173.7 | Cancer History | Surgery | Metastatic | Intermediate | II | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 143.96 | 127.01 | 220.42 | Multi-Beam | 64.33 | Organ-Sparing | DVH_P0333 | /simulated/path/P0333_synthetic_image.nii | /simulated/path/SIM-0333_GTV_segmentation.nii | /simulated/path/SIM-0333_CTV_segmentation.nii | /simulated/path/SIM-0333_PTV_segmentation.nii |
SIM-0334 | 37 | Male | 72.6 | 181.9 | Hypertension | Surgery | Astrocytoma | Intermediate | III | PET | Isotropic | Contrast-Enhanced | Philips | 15.33 | 95.17 | 101.87 | Single | 21.72 | Maximize Tumor Dose | DVH_P0334 | /simulated/path/P0334_synthetic_image.nii | /simulated/path/SIM-0334_GTV_segmentation.nii | /simulated/path/SIM-0334_CTV_segmentation.nii | /simulated/path/SIM-0334_PTV_segmentation.nii |
SIM-0335 | 67 | Male | 71.1 | 182 | Cardiac Issues | Radiotherapy | Meningioma | High | I | CT | Isotropic | Non-Contrast-Enhanced | Philips | 20.9 | 192.18 | 44.16 | Multi-Beam | 60.36 | Maximize Tumor Dose | DVH_P0335 | /simulated/path/P0335_synthetic_image.nii | /simulated/path/SIM-0335_GTV_segmentation.nii | /simulated/path/SIM-0335_CTV_segmentation.nii | /simulated/path/SIM-0335_PTV_segmentation.nii |
SIM-0336 | 44 | Male | 88.7 | 183.7 | Cancer History | Chemotherapy | Meningioma | Low | II | CT | Isotropic | Non-Contrast-Enhanced | GE | 108.97 | 160.32 | 161.49 | Single | 26.16 | Organ-Sparing | DVH_P0336 | /simulated/path/P0336_synthetic_image.nii | /simulated/path/SIM-0336_GTV_segmentation.nii | /simulated/path/SIM-0336_CTV_segmentation.nii | /simulated/path/SIM-0336_PTV_segmentation.nii |
SIM-0337 | 76 | Male | 85.4 | 153.8 | Diabetes | Chemotherapy | Glioblastoma | Intermediate | IV | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 130 | 46.09 | 56.73 | Multi-Beam | 59.39 | Organ-Sparing | DVH_P0337 | /simulated/path/P0337_synthetic_image.nii | /simulated/path/SIM-0337_GTV_segmentation.nii | /simulated/path/SIM-0337_CTV_segmentation.nii | /simulated/path/SIM-0337_PTV_segmentation.nii |
SIM-0338 | 25 | Male | 90.9 | 194.2 | Cardiac Issues | null | Metastatic | Intermediate | II | MRI | Isotropic | Non-Contrast-Enhanced | Siemens | 139.8 | 6.07 | 204.78 | Multi-Beam | 82.21 | Organ-Sparing | DVH_P0338 | /simulated/path/P0338_synthetic_image.nii | /simulated/path/SIM-0338_GTV_segmentation.nii | /simulated/path/SIM-0338_CTV_segmentation.nii | /simulated/path/SIM-0338_PTV_segmentation.nii |
SIM-0339 | 58 | Female | 50.2 | 187.7 | Cancer History | Surgery | Meningioma | Low | I | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 43.09 | 48.94 | 104.62 | Multi-Beam | 96.71 | Maximize Tumor Dose | DVH_P0339 | /simulated/path/P0339_synthetic_image.nii | /simulated/path/SIM-0339_GTV_segmentation.nii | /simulated/path/SIM-0339_CTV_segmentation.nii | /simulated/path/SIM-0339_PTV_segmentation.nii |
SIM-0340 | 77 | Male | 95.5 | 171.8 | Hypertension | Radiotherapy | Glioblastoma | Intermediate | III | PET | Isotropic | Contrast-Enhanced | Philips | 95.49 | 25.85 | 22.46 | Single | 31.19 | Maximize Tumor Dose | DVH_P0340 | /simulated/path/P0340_synthetic_image.nii | /simulated/path/SIM-0340_GTV_segmentation.nii | /simulated/path/SIM-0340_CTV_segmentation.nii | /simulated/path/SIM-0340_PTV_segmentation.nii |
SIM-0341 | 46 | Female | 96.8 | 180.8 | null | null | Glioblastoma | Low | III | CT | Anisotropic | Contrast-Enhanced | GE | 55.83 | 177.75 | 66.56 | Multi-Beam | 23.08 | Maximize Tumor Dose | DVH_P0341 | /simulated/path/P0341_synthetic_image.nii | /simulated/path/SIM-0341_GTV_segmentation.nii | /simulated/path/SIM-0341_CTV_segmentation.nii | /simulated/path/SIM-0341_PTV_segmentation.nii |
SIM-0342 | 68 | Female | 94.6 | 190.2 | Diabetes | Surgery | Astrocytoma | Low | II | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 134.01 | 104.61 | 159.01 | Single | 50.58 | Maximize Tumor Dose | DVH_P0342 | /simulated/path/P0342_synthetic_image.nii | /simulated/path/SIM-0342_GTV_segmentation.nii | /simulated/path/SIM-0342_CTV_segmentation.nii | /simulated/path/SIM-0342_PTV_segmentation.nii |
SIM-0343 | 28 | Male | 73.5 | 189.8 | Cancer History | Chemotherapy | Metastatic | Intermediate | II | MRI | Isotropic | Non-Contrast-Enhanced | Siemens | 50.69 | 178.05 | 39 | Multi-Beam | 39.67 | Balanced | DVH_P0343 | /simulated/path/P0343_synthetic_image.nii | /simulated/path/SIM-0343_GTV_segmentation.nii | /simulated/path/SIM-0343_CTV_segmentation.nii | /simulated/path/SIM-0343_PTV_segmentation.nii |
SIM-0344 | 27 | Female | 53.4 | 152.7 | Diabetes | Surgery | Metastatic | Intermediate | II | CT | Isotropic | Contrast-Enhanced | GE | 114.55 | 172.62 | 66.56 | Multi-Beam | 77.08 | Organ-Sparing | DVH_P0344 | /simulated/path/P0344_synthetic_image.nii | /simulated/path/SIM-0344_GTV_segmentation.nii | /simulated/path/SIM-0344_CTV_segmentation.nii | /simulated/path/SIM-0344_PTV_segmentation.nii |
SIM-0345 | 67 | Male | 96 | 199.8 | Hypertension | null | Metastatic | Low | IV | MRI | Anisotropic | Contrast-Enhanced | Siemens | 56.73 | 150.52 | 189.71 | Multi-Beam | 92.4 | Maximize Tumor Dose | DVH_P0345 | /simulated/path/P0345_synthetic_image.nii | /simulated/path/SIM-0345_GTV_segmentation.nii | /simulated/path/SIM-0345_CTV_segmentation.nii | /simulated/path/SIM-0345_PTV_segmentation.nii |
SIM-0346 | 63 | Male | 59.1 | 184.2 | Cancer History | null | Metastatic | Low | I | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 119.68 | 57 | 141.14 | Single | 72.64 | Maximize Tumor Dose | DVH_P0346 | /simulated/path/P0346_synthetic_image.nii | /simulated/path/SIM-0346_GTV_segmentation.nii | /simulated/path/SIM-0346_CTV_segmentation.nii | /simulated/path/SIM-0346_PTV_segmentation.nii |
SIM-0347 | 32 | Female | 81.8 | 152.3 | Hypertension | Surgery | Metastatic | Low | I | CT | Anisotropic | Contrast-Enhanced | Siemens | 14.06 | 37.25 | 71.19 | Multi-Beam | 32.96 | Balanced | DVH_P0347 | /simulated/path/P0347_synthetic_image.nii | /simulated/path/SIM-0347_GTV_segmentation.nii | /simulated/path/SIM-0347_CTV_segmentation.nii | /simulated/path/SIM-0347_PTV_segmentation.nii |
SIM-0348 | 55 | Male | 75.6 | 196.8 | Cancer History | Radiotherapy | Meningioma | Low | IV | PET | Isotropic | Contrast-Enhanced | GE | 106.9 | 143.38 | 242.49 | Single | 54.9 | Organ-Sparing | DVH_P0348 | /simulated/path/P0348_synthetic_image.nii | /simulated/path/SIM-0348_GTV_segmentation.nii | /simulated/path/SIM-0348_CTV_segmentation.nii | /simulated/path/SIM-0348_PTV_segmentation.nii |
SIM-0349 | 34 | Female | 55.3 | 159.5 | Hypertension | null | Astrocytoma | High | II | CT | Isotropic | Non-Contrast-Enhanced | Philips | 39.62 | 199.68 | 60.64 | Multi-Beam | 50.58 | Maximize Tumor Dose | DVH_P0349 | /simulated/path/P0349_synthetic_image.nii | /simulated/path/SIM-0349_GTV_segmentation.nii | /simulated/path/SIM-0349_CTV_segmentation.nii | /simulated/path/SIM-0349_PTV_segmentation.nii |
SIM-0350 | 21 | Female | 61.5 | 176.8 | Cancer History | Chemotherapy | Metastatic | Low | I | PET | Isotropic | Contrast-Enhanced | Philips | 23.84 | 67.23 | 215.93 | Single | 57.74 | Maximize Tumor Dose | DVH_P0350 | /simulated/path/P0350_synthetic_image.nii | /simulated/path/SIM-0350_GTV_segmentation.nii | /simulated/path/SIM-0350_CTV_segmentation.nii | /simulated/path/SIM-0350_PTV_segmentation.nii |
SIM-0351 | 18 | Female | 51 | 181.7 | Cardiac Issues | Surgery | Metastatic | High | IV | PET | Isotropic | Non-Contrast-Enhanced | Philips | 35.61 | 198.25 | 239.54 | Multi-Beam | 35.23 | Maximize Tumor Dose | DVH_P0351 | /simulated/path/P0351_synthetic_image.nii | /simulated/path/SIM-0351_GTV_segmentation.nii | /simulated/path/SIM-0351_CTV_segmentation.nii | /simulated/path/SIM-0351_PTV_segmentation.nii |
SIM-0352 | 29 | Female | 95 | 181.3 | Cancer History | Chemotherapy | Glioblastoma | Low | III | CT | Isotropic | Contrast-Enhanced | Siemens | 29.61 | 61.96 | 158.05 | Single | 91.41 | Maximize Tumor Dose | DVH_P0352 | /simulated/path/P0352_synthetic_image.nii | /simulated/path/SIM-0352_GTV_segmentation.nii | /simulated/path/SIM-0352_CTV_segmentation.nii | /simulated/path/SIM-0352_PTV_segmentation.nii |
SIM-0353 | 83 | Male | 77.4 | 170.8 | Diabetes | Radiotherapy | Glioblastoma | High | II | PET | Anisotropic | Non-Contrast-Enhanced | Siemens | 24.29 | 86.95 | 33.93 | Multi-Beam | 77.66 | Maximize Tumor Dose | DVH_P0353 | /simulated/path/P0353_synthetic_image.nii | /simulated/path/SIM-0353_GTV_segmentation.nii | /simulated/path/SIM-0353_CTV_segmentation.nii | /simulated/path/SIM-0353_PTV_segmentation.nii |
SIM-0354 | 72 | Male | 84.6 | 168.8 | Cancer History | Surgery | Glioblastoma | High | II | PET | Isotropic | Contrast-Enhanced | Philips | 7.66 | 22.36 | 70.85 | Multi-Beam | 33.45 | Balanced | DVH_P0354 | /simulated/path/P0354_synthetic_image.nii | /simulated/path/SIM-0354_GTV_segmentation.nii | /simulated/path/SIM-0354_CTV_segmentation.nii | /simulated/path/SIM-0354_PTV_segmentation.nii |
SIM-0355 | 65 | Female | 70.2 | 185.9 | Cancer History | null | Metastatic | Intermediate | III | PET | Isotropic | Contrast-Enhanced | Siemens | 6.46 | 46.33 | 157.75 | Single | 75.37 | Maximize Tumor Dose | DVH_P0355 | /simulated/path/P0355_synthetic_image.nii | /simulated/path/SIM-0355_GTV_segmentation.nii | /simulated/path/SIM-0355_CTV_segmentation.nii | /simulated/path/SIM-0355_PTV_segmentation.nii |
SIM-0356 | 77 | Male | 54.2 | 179 | null | Radiotherapy | Astrocytoma | Low | IV | MRI | Isotropic | Contrast-Enhanced | Philips | 135.3 | 95.69 | 248.94 | Single | 92.85 | Balanced | DVH_P0356 | /simulated/path/P0356_synthetic_image.nii | /simulated/path/SIM-0356_GTV_segmentation.nii | /simulated/path/SIM-0356_CTV_segmentation.nii | /simulated/path/SIM-0356_PTV_segmentation.nii |
SIM-0357 | 70 | Female | 55.5 | 198.1 | null | null | Meningioma | Low | IV | CT | Anisotropic | Non-Contrast-Enhanced | Philips | 71.49 | 147.09 | 130.1 | Single | 81.47 | Organ-Sparing | DVH_P0357 | /simulated/path/P0357_synthetic_image.nii | /simulated/path/SIM-0357_GTV_segmentation.nii | /simulated/path/SIM-0357_CTV_segmentation.nii | /simulated/path/SIM-0357_PTV_segmentation.nii |
SIM-0358 | 53 | Female | 93 | 186.4 | Cancer History | Radiotherapy | Meningioma | High | I | PET | Isotropic | Non-Contrast-Enhanced | GE | 84.31 | 12.24 | 214.65 | Multi-Beam | 19.55 | Organ-Sparing | DVH_P0358 | /simulated/path/P0358_synthetic_image.nii | /simulated/path/SIM-0358_GTV_segmentation.nii | /simulated/path/SIM-0358_CTV_segmentation.nii | /simulated/path/SIM-0358_PTV_segmentation.nii |
SIM-0359 | 31 | Female | 69.6 | 161.1 | Diabetes | Surgery | Glioblastoma | High | I | PET | Isotropic | Non-Contrast-Enhanced | GE | 58.44 | 100.53 | 178.57 | Single | 77.21 | Maximize Tumor Dose | DVH_P0359 | /simulated/path/P0359_synthetic_image.nii | /simulated/path/SIM-0359_GTV_segmentation.nii | /simulated/path/SIM-0359_CTV_segmentation.nii | /simulated/path/SIM-0359_PTV_segmentation.nii |
SIM-0360 | 76 | Male | 68.5 | 189.2 | Hypertension | null | Metastatic | Intermediate | II | MRI | Anisotropic | Contrast-Enhanced | Philips | 123.19 | 185.56 | 226.52 | Multi-Beam | 15.56 | Organ-Sparing | DVH_P0360 | /simulated/path/P0360_synthetic_image.nii | /simulated/path/SIM-0360_GTV_segmentation.nii | /simulated/path/SIM-0360_CTV_segmentation.nii | /simulated/path/SIM-0360_PTV_segmentation.nii |
SIM-0361 | 57 | Female | 93.6 | 170 | Hypertension | Radiotherapy | Metastatic | High | I | PET | Anisotropic | Contrast-Enhanced | Siemens | 48.93 | 97.75 | 205.43 | Multi-Beam | 85.8 | Balanced | DVH_P0361 | /simulated/path/P0361_synthetic_image.nii | /simulated/path/SIM-0361_GTV_segmentation.nii | /simulated/path/SIM-0361_CTV_segmentation.nii | /simulated/path/SIM-0361_PTV_segmentation.nii |
SIM-0362 | 22 | Male | 79.3 | 181.4 | Cancer History | Chemotherapy | Glioblastoma | Intermediate | I | PET | Isotropic | Non-Contrast-Enhanced | Philips | 90.58 | 79.79 | 172.44 | Multi-Beam | 13.99 | Balanced | DVH_P0362 | /simulated/path/P0362_synthetic_image.nii | /simulated/path/SIM-0362_GTV_segmentation.nii | /simulated/path/SIM-0362_CTV_segmentation.nii | /simulated/path/SIM-0362_PTV_segmentation.nii |
SIM-0363 | 27 | Male | 94.6 | 193.9 | Cancer History | Radiotherapy | Metastatic | Low | II | CT | Anisotropic | Contrast-Enhanced | Philips | 64.24 | 99.65 | 23.81 | Single | 82.07 | Organ-Sparing | DVH_P0363 | /simulated/path/P0363_synthetic_image.nii | /simulated/path/SIM-0363_GTV_segmentation.nii | /simulated/path/SIM-0363_CTV_segmentation.nii | /simulated/path/SIM-0363_PTV_segmentation.nii |
SIM-0364 | 34 | Female | 90.7 | 180.6 | null | Surgery | Meningioma | Low | IV | PET | Anisotropic | Non-Contrast-Enhanced | GE | 149.97 | 34.98 | 181.69 | Multi-Beam | 84.23 | Organ-Sparing | DVH_P0364 | /simulated/path/P0364_synthetic_image.nii | /simulated/path/SIM-0364_GTV_segmentation.nii | /simulated/path/SIM-0364_CTV_segmentation.nii | /simulated/path/SIM-0364_PTV_segmentation.nii |
SIM-0365 | 27 | Male | 98.1 | 172.2 | Cardiac Issues | Surgery | Glioblastoma | High | III | CT | Isotropic | Contrast-Enhanced | Siemens | 111.37 | 169.52 | 77.21 | Multi-Beam | 31.74 | Organ-Sparing | DVH_P0365 | /simulated/path/P0365_synthetic_image.nii | /simulated/path/SIM-0365_GTV_segmentation.nii | /simulated/path/SIM-0365_CTV_segmentation.nii | /simulated/path/SIM-0365_PTV_segmentation.nii |
SIM-0366 | 48 | Male | 59 | 173.4 | Diabetes | null | Meningioma | Low | III | MRI | Isotropic | Contrast-Enhanced | GE | 33.99 | 110.81 | 200.38 | Single | 89.41 | Organ-Sparing | DVH_P0366 | /simulated/path/P0366_synthetic_image.nii | /simulated/path/SIM-0366_GTV_segmentation.nii | /simulated/path/SIM-0366_CTV_segmentation.nii | /simulated/path/SIM-0366_PTV_segmentation.nii |
SIM-0367 | 47 | Female | 64.9 | 181.9 | Diabetes | Surgery | Astrocytoma | High | II | CT | Anisotropic | Contrast-Enhanced | Philips | 19.01 | 8.3 | 41.6 | Single | 24.84 | Maximize Tumor Dose | DVH_P0367 | /simulated/path/P0367_synthetic_image.nii | /simulated/path/SIM-0367_GTV_segmentation.nii | /simulated/path/SIM-0367_CTV_segmentation.nii | /simulated/path/SIM-0367_PTV_segmentation.nii |
SIM-0368 | 80 | Female | 78.5 | 162 | Hypertension | null | Glioblastoma | Intermediate | I | MRI | Isotropic | Non-Contrast-Enhanced | Philips | 1.4 | 157.01 | 200.41 | Multi-Beam | 91.11 | Organ-Sparing | DVH_P0368 | /simulated/path/P0368_synthetic_image.nii | /simulated/path/SIM-0368_GTV_segmentation.nii | /simulated/path/SIM-0368_CTV_segmentation.nii | /simulated/path/SIM-0368_PTV_segmentation.nii |
SIM-0369 | 85 | Male | 67.3 | 169.5 | Diabetes | Surgery | Metastatic | Intermediate | II | CT | Anisotropic | Contrast-Enhanced | Philips | 95.59 | 13.27 | 57.03 | Multi-Beam | 22 | Maximize Tumor Dose | DVH_P0369 | /simulated/path/P0369_synthetic_image.nii | /simulated/path/SIM-0369_GTV_segmentation.nii | /simulated/path/SIM-0369_CTV_segmentation.nii | /simulated/path/SIM-0369_PTV_segmentation.nii |
SIM-0370 | 81 | Female | 73.6 | 156.1 | null | Radiotherapy | Glioblastoma | High | III | PET | Anisotropic | Non-Contrast-Enhanced | GE | 6.99 | 87.59 | 11.33 | Single | 73.33 | Organ-Sparing | DVH_P0370 | /simulated/path/P0370_synthetic_image.nii | /simulated/path/SIM-0370_GTV_segmentation.nii | /simulated/path/SIM-0370_CTV_segmentation.nii | /simulated/path/SIM-0370_PTV_segmentation.nii |
SIM-0371 | 29 | Male | 74.6 | 173.5 | Diabetes | null | Glioblastoma | Low | II | PET | Anisotropic | Contrast-Enhanced | Philips | 32.59 | 85.65 | 77.74 | Single | 87.29 | Maximize Tumor Dose | DVH_P0371 | /simulated/path/P0371_synthetic_image.nii | /simulated/path/SIM-0371_GTV_segmentation.nii | /simulated/path/SIM-0371_CTV_segmentation.nii | /simulated/path/SIM-0371_PTV_segmentation.nii |
SIM-0372 | 75 | Male | 80.2 | 162.8 | Hypertension | null | Metastatic | High | II | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 124.43 | 122.55 | 2.27 | Single | 61.97 | Maximize Tumor Dose | DVH_P0372 | /simulated/path/P0372_synthetic_image.nii | /simulated/path/SIM-0372_GTV_segmentation.nii | /simulated/path/SIM-0372_CTV_segmentation.nii | /simulated/path/SIM-0372_PTV_segmentation.nii |
SIM-0373 | 66 | Male | 58.1 | 198.3 | Hypertension | Chemotherapy | Meningioma | Intermediate | II | PET | Anisotropic | Contrast-Enhanced | GE | 40.76 | 121.29 | 66.09 | Multi-Beam | 39.13 | Maximize Tumor Dose | DVH_P0373 | /simulated/path/P0373_synthetic_image.nii | /simulated/path/SIM-0373_GTV_segmentation.nii | /simulated/path/SIM-0373_CTV_segmentation.nii | /simulated/path/SIM-0373_PTV_segmentation.nii |
SIM-0374 | 76 | Female | 65.1 | 153.1 | Cardiac Issues | null | Glioblastoma | High | III | CT | Anisotropic | Non-Contrast-Enhanced | GE | 72.36 | 198.22 | 99.96 | Multi-Beam | 48.06 | Organ-Sparing | DVH_P0374 | /simulated/path/P0374_synthetic_image.nii | /simulated/path/SIM-0374_GTV_segmentation.nii | /simulated/path/SIM-0374_CTV_segmentation.nii | /simulated/path/SIM-0374_PTV_segmentation.nii |
SIM-0375 | 30 | Female | 67.3 | 162.6 | Diabetes | Chemotherapy | Astrocytoma | Low | I | MRI | Isotropic | Contrast-Enhanced | Siemens | 37.51 | 97.43 | 159.03 | Single | 54.2 | Maximize Tumor Dose | DVH_P0375 | /simulated/path/P0375_synthetic_image.nii | /simulated/path/SIM-0375_GTV_segmentation.nii | /simulated/path/SIM-0375_CTV_segmentation.nii | /simulated/path/SIM-0375_PTV_segmentation.nii |
SIM-0376 | 47 | Female | 52.3 | 174.8 | Cancer History | Radiotherapy | Meningioma | High | II | PET | Anisotropic | Contrast-Enhanced | Siemens | 45.99 | 186.78 | 68.73 | Multi-Beam | 62.27 | Organ-Sparing | DVH_P0376 | /simulated/path/P0376_synthetic_image.nii | /simulated/path/SIM-0376_GTV_segmentation.nii | /simulated/path/SIM-0376_CTV_segmentation.nii | /simulated/path/SIM-0376_PTV_segmentation.nii |
SIM-0377 | 80 | Female | 88.3 | 174.9 | null | null | Meningioma | High | III | MRI | Isotropic | Non-Contrast-Enhanced | Philips | 31.98 | 6.93 | 76.3 | Multi-Beam | 29.13 | Organ-Sparing | DVH_P0377 | /simulated/path/P0377_synthetic_image.nii | /simulated/path/SIM-0377_GTV_segmentation.nii | /simulated/path/SIM-0377_CTV_segmentation.nii | /simulated/path/SIM-0377_PTV_segmentation.nii |
SIM-0378 | 36 | Male | 83.7 | 159.3 | Cancer History | Radiotherapy | Glioblastoma | Low | I | CT | Isotropic | Contrast-Enhanced | GE | 25.65 | 121.44 | 110.24 | Multi-Beam | 68.51 | Organ-Sparing | DVH_P0378 | /simulated/path/P0378_synthetic_image.nii | /simulated/path/SIM-0378_GTV_segmentation.nii | /simulated/path/SIM-0378_CTV_segmentation.nii | /simulated/path/SIM-0378_PTV_segmentation.nii |
SIM-0379 | 43 | Male | 89.8 | 199.8 | Hypertension | Chemotherapy | Astrocytoma | High | IV | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 41.42 | 129.5 | 153.58 | Single | 68.1 | Organ-Sparing | DVH_P0379 | /simulated/path/P0379_synthetic_image.nii | /simulated/path/SIM-0379_GTV_segmentation.nii | /simulated/path/SIM-0379_CTV_segmentation.nii | /simulated/path/SIM-0379_PTV_segmentation.nii |
SIM-0380 | 35 | Female | 60.7 | 158.9 | null | Chemotherapy | Glioblastoma | High | I | PET | Isotropic | Non-Contrast-Enhanced | Philips | 102.51 | 166.16 | 140.07 | Single | 71.9 | Maximize Tumor Dose | DVH_P0380 | /simulated/path/P0380_synthetic_image.nii | /simulated/path/SIM-0380_GTV_segmentation.nii | /simulated/path/SIM-0380_CTV_segmentation.nii | /simulated/path/SIM-0380_PTV_segmentation.nii |
SIM-0381 | 31 | Female | 81.8 | 197.9 | Cardiac Issues | Surgery | Astrocytoma | Low | II | PET | Anisotropic | Contrast-Enhanced | Siemens | 25.15 | 128.22 | 113.79 | Multi-Beam | 85.35 | Organ-Sparing | DVH_P0381 | /simulated/path/P0381_synthetic_image.nii | /simulated/path/SIM-0381_GTV_segmentation.nii | /simulated/path/SIM-0381_CTV_segmentation.nii | /simulated/path/SIM-0381_PTV_segmentation.nii |
SIM-0382 | 67 | Male | 84.1 | 197.9 | Cardiac Issues | Radiotherapy | Meningioma | High | III | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 146.3 | 94.08 | 95.68 | Single | 51.65 | Organ-Sparing | DVH_P0382 | /simulated/path/P0382_synthetic_image.nii | /simulated/path/SIM-0382_GTV_segmentation.nii | /simulated/path/SIM-0382_CTV_segmentation.nii | /simulated/path/SIM-0382_PTV_segmentation.nii |
SIM-0383 | 55 | Female | 84.4 | 195.3 | Diabetes | Radiotherapy | Meningioma | Intermediate | II | MRI | Isotropic | Contrast-Enhanced | Philips | 73.53 | 34.33 | 207.26 | Multi-Beam | 32.4 | Maximize Tumor Dose | DVH_P0383 | /simulated/path/P0383_synthetic_image.nii | /simulated/path/SIM-0383_GTV_segmentation.nii | /simulated/path/SIM-0383_CTV_segmentation.nii | /simulated/path/SIM-0383_PTV_segmentation.nii |
SIM-0384 | 58 | Male | 53.1 | 159.5 | Cardiac Issues | Radiotherapy | Metastatic | High | III | MRI | Anisotropic | Contrast-Enhanced | Philips | 136.83 | 196.88 | 2.43 | Multi-Beam | 89.32 | Organ-Sparing | DVH_P0384 | /simulated/path/P0384_synthetic_image.nii | /simulated/path/SIM-0384_GTV_segmentation.nii | /simulated/path/SIM-0384_CTV_segmentation.nii | /simulated/path/SIM-0384_PTV_segmentation.nii |
SIM-0385 | 45 | Male | 67.1 | 185.4 | Hypertension | Surgery | Astrocytoma | Intermediate | I | PET | Isotropic | Non-Contrast-Enhanced | Philips | 44.11 | 43.21 | 10.02 | Single | 12.58 | Balanced | DVH_P0385 | /simulated/path/P0385_synthetic_image.nii | /simulated/path/SIM-0385_GTV_segmentation.nii | /simulated/path/SIM-0385_CTV_segmentation.nii | /simulated/path/SIM-0385_PTV_segmentation.nii |
SIM-0386 | 72 | Male | 57.1 | 156.1 | Hypertension | Radiotherapy | Astrocytoma | Intermediate | III | PET | Anisotropic | Non-Contrast-Enhanced | GE | 86.01 | 196.37 | 23.08 | Multi-Beam | 13.94 | Maximize Tumor Dose | DVH_P0386 | /simulated/path/P0386_synthetic_image.nii | /simulated/path/SIM-0386_GTV_segmentation.nii | /simulated/path/SIM-0386_CTV_segmentation.nii | /simulated/path/SIM-0386_PTV_segmentation.nii |
SIM-0387 | 81 | Male | 85.5 | 156.4 | Cancer History | Chemotherapy | Metastatic | Intermediate | IV | MRI | Anisotropic | Non-Contrast-Enhanced | GE | 41.62 | 79.51 | 162.62 | Multi-Beam | 18.91 | Maximize Tumor Dose | DVH_P0387 | /simulated/path/P0387_synthetic_image.nii | /simulated/path/SIM-0387_GTV_segmentation.nii | /simulated/path/SIM-0387_CTV_segmentation.nii | /simulated/path/SIM-0387_PTV_segmentation.nii |
SIM-0388 | 55 | Female | 62.1 | 151.8 | Hypertension | Radiotherapy | Meningioma | Low | IV | MRI | Isotropic | Non-Contrast-Enhanced | Philips | 41.32 | 115.94 | 135.21 | Single | 92.25 | Maximize Tumor Dose | DVH_P0388 | /simulated/path/P0388_synthetic_image.nii | /simulated/path/SIM-0388_GTV_segmentation.nii | /simulated/path/SIM-0388_CTV_segmentation.nii | /simulated/path/SIM-0388_PTV_segmentation.nii |
SIM-0389 | 71 | Female | 90.4 | 156.2 | Cancer History | Chemotherapy | Metastatic | Intermediate | IV | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 100.99 | 27.42 | 10.69 | Single | 21.79 | Organ-Sparing | DVH_P0389 | /simulated/path/P0389_synthetic_image.nii | /simulated/path/SIM-0389_GTV_segmentation.nii | /simulated/path/SIM-0389_CTV_segmentation.nii | /simulated/path/SIM-0389_PTV_segmentation.nii |
SIM-0390 | 75 | Female | 70.8 | 187.1 | null | Surgery | Astrocytoma | Intermediate | II | MRI | Anisotropic | Contrast-Enhanced | Philips | 123.93 | 161.64 | 116.85 | Single | 32.5 | Organ-Sparing | DVH_P0390 | /simulated/path/P0390_synthetic_image.nii | /simulated/path/SIM-0390_GTV_segmentation.nii | /simulated/path/SIM-0390_CTV_segmentation.nii | /simulated/path/SIM-0390_PTV_segmentation.nii |
SIM-0391 | 30 | Male | 72.3 | 154.1 | Diabetes | null | Meningioma | Intermediate | IV | MRI | Isotropic | Non-Contrast-Enhanced | Siemens | 112.6 | 45.15 | 155.65 | Single | 91 | Organ-Sparing | DVH_P0391 | /simulated/path/P0391_synthetic_image.nii | /simulated/path/SIM-0391_GTV_segmentation.nii | /simulated/path/SIM-0391_CTV_segmentation.nii | /simulated/path/SIM-0391_PTV_segmentation.nii |
SIM-0392 | 52 | Female | 67.9 | 168.2 | Diabetes | Surgery | Glioblastoma | Low | I | CT | Isotropic | Non-Contrast-Enhanced | Siemens | 10.09 | 95.2 | 26.38 | Multi-Beam | 32.94 | Balanced | DVH_P0392 | /simulated/path/P0392_synthetic_image.nii | /simulated/path/SIM-0392_GTV_segmentation.nii | /simulated/path/SIM-0392_CTV_segmentation.nii | /simulated/path/SIM-0392_PTV_segmentation.nii |
SIM-0393 | 24 | Male | 59.7 | 163.6 | Cardiac Issues | Surgery | Glioblastoma | High | II | MRI | Isotropic | Non-Contrast-Enhanced | Siemens | 104.1 | 67.68 | 219.49 | Single | 53.21 | Organ-Sparing | DVH_P0393 | /simulated/path/P0393_synthetic_image.nii | /simulated/path/SIM-0393_GTV_segmentation.nii | /simulated/path/SIM-0393_CTV_segmentation.nii | /simulated/path/SIM-0393_PTV_segmentation.nii |
SIM-0394 | 76 | Female | 65.3 | 151.4 | Cancer History | Radiotherapy | Astrocytoma | Low | I | MRI | Anisotropic | Contrast-Enhanced | Siemens | 129.24 | 129.82 | 57.15 | Single | 33.43 | Organ-Sparing | DVH_P0394 | /simulated/path/P0394_synthetic_image.nii | /simulated/path/SIM-0394_GTV_segmentation.nii | /simulated/path/SIM-0394_CTV_segmentation.nii | /simulated/path/SIM-0394_PTV_segmentation.nii |
SIM-0395 | 32 | Male | 54 | 172 | null | null | Meningioma | High | I | PET | Isotropic | Contrast-Enhanced | GE | 69.31 | 104.81 | 238.57 | Single | 69.76 | Organ-Sparing | DVH_P0395 | /simulated/path/P0395_synthetic_image.nii | /simulated/path/SIM-0395_GTV_segmentation.nii | /simulated/path/SIM-0395_CTV_segmentation.nii | /simulated/path/SIM-0395_PTV_segmentation.nii |
SIM-0396 | 76 | Female | 94.5 | 185.2 | Diabetes | Radiotherapy | Astrocytoma | High | IV | MRI | Isotropic | Contrast-Enhanced | Siemens | 121.94 | 132.2 | 194.01 | Multi-Beam | 70.49 | Balanced | DVH_P0396 | /simulated/path/P0396_synthetic_image.nii | /simulated/path/SIM-0396_GTV_segmentation.nii | /simulated/path/SIM-0396_CTV_segmentation.nii | /simulated/path/SIM-0396_PTV_segmentation.nii |
SIM-0397 | 53 | Male | 77.8 | 183.6 | Hypertension | null | Astrocytoma | Intermediate | III | PET | Isotropic | Contrast-Enhanced | GE | 107.16 | 83.8 | 17.82 | Multi-Beam | 66.53 | Maximize Tumor Dose | DVH_P0397 | /simulated/path/P0397_synthetic_image.nii | /simulated/path/SIM-0397_GTV_segmentation.nii | /simulated/path/SIM-0397_CTV_segmentation.nii | /simulated/path/SIM-0397_PTV_segmentation.nii |
SIM-0398 | 84 | Female | 72.2 | 175.9 | Cardiac Issues | Surgery | Metastatic | High | III | MRI | Isotropic | Non-Contrast-Enhanced | GE | 123.92 | 59.34 | 200.65 | Multi-Beam | 19.48 | Organ-Sparing | DVH_P0398 | /simulated/path/P0398_synthetic_image.nii | /simulated/path/SIM-0398_GTV_segmentation.nii | /simulated/path/SIM-0398_CTV_segmentation.nii | /simulated/path/SIM-0398_PTV_segmentation.nii |
SIM-0399 | 71 | Female | 63.1 | 191.1 | Cardiac Issues | Chemotherapy | Metastatic | High | I | PET | Anisotropic | Non-Contrast-Enhanced | Siemens | 35.41 | 29.61 | 197.05 | Multi-Beam | 68.24 | Balanced | DVH_P0399 | /simulated/path/P0399_synthetic_image.nii | /simulated/path/SIM-0399_GTV_segmentation.nii | /simulated/path/SIM-0399_CTV_segmentation.nii | /simulated/path/SIM-0399_PTV_segmentation.nii |
SIM-0400 | 73 | Female | 68 | 171.6 | null | Surgery | Glioblastoma | Intermediate | IV | MRI | Isotropic | Non-Contrast-Enhanced | Philips | 22.9 | 163.54 | 76.16 | Multi-Beam | 60.3 | Organ-Sparing | DVH_P0400 | /simulated/path/P0400_synthetic_image.nii | /simulated/path/SIM-0400_GTV_segmentation.nii | /simulated/path/SIM-0400_CTV_segmentation.nii | /simulated/path/SIM-0400_PTV_segmentation.nii |